Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men: Prospective results from the Quebec cardiovascular study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 6, 1997, Pages 1098-1105

  Lamarche, Benoît ^a   Moorjani, Sital ^a   Cantin, Bernard ^a   Dagenais, Gilles R ^b   Lupien, Paul J ^a   Després, Jean Pierre ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

HDL subfractions; Ischemic heart disease

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; HIGH DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; CANADA; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CORONARY RISK; DISEASE ASSOCIATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; BLOOD; BODY MASS; CLASSIFICATION; HEART MUSCLE ISCHEMIA; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; RISK; RISK FACTOR;

ADULT; BODY MASS INDEX; CHOLESTEROL, HDL; HUMANS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROSPECTIVE STUDIES; QUEBEC; RISK; RISK FACTORS;

EID: 0030610965     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.6.1098     Document Type: Article

References (38)

1. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. Am J Med. 1977;62:707-714.
2. Miller NE, Forde OH, Thelle DS, Mjos OD. The Tromso Heart Study: high-density lipoprotein as a protective factor against coronary heart disease: a prospective case-control study. Lancet. 1977;1:965-967.
3. Castelli WP, Doyles JT, Gordon T. HDL-cholesterol and other lipids in coronary heart disease: the Cooperative Lipoprotein Phenotyping Study. Circulation. 1977;55:767-772.
4. Gordon DJ, Rifkind BM. High density lipoprotein: the clinical implications of recent studies. A' Engl J Med. 1989;321:1311-1316.
5. Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Am J Cardiol. 1992;70:733-737.
6. Manninen V, Tenkanen L, Koshinen P, Huttunen JK, Mänttäri M, Heinonen OP, Frick MH. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study: implications for treatment. Circulation. 1992;85:37-45.
7. Barr DP, Russ EM, Eder HA. Protein lipid relationship in human plasma, II: in atherosclerosis and related conditions. Am J Med. 1951; 11:480-493.
8. Silverman DI, Ginsburg GS, Pasternak RC. High density lipoprotein subfractions. Am J Med. 1993:94:636-645.
9. Gofman JW, Young W, Tandy R. Ischemic heart disease, atherosclerosis and longevity. Circulation. 1966:34:79-97.
10. Miller NE. Associations of high density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J. 1987;113:589-587.
11. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med. 1991:325:373-381.
12. 3 cholesterol subfractions with the development of ischemic heart disease in British men: the Caerphilly and Speedwell Collaborative Heart Disease studies. Circulation. 1994:90:769-774.
13. 3 subfractions, and the risk of acute myocardial infarction: a prospective study in eastern Finnish men. Circulation. 1991:84:129-139.
14. Dagenais GR, Robitaille NM, Lupien PJ, Christen A, Gingras S, Moorjani S, Meyer F, Rochon J. First coronary heart disease event rates in relation to major risk factors: Québec Cardiovascular Study. Can J Cardiol. 1990;6:274-280.
15. Lupien PJ, Moorjani S, Rochon J, Dagenais GR, Fleury LA, Jobin J, Robitaille NM. Lipid profile of a French-Canadian population, I: association of plasma lipid and lipoprotein levels with age, relative body weight and education. Can Med Assoc J. 1985:133: 1127-1133.
16. Marmot MG. Alcohol and coronary heart disease. Int J Epidemiol. 1984;13:160-167.
17. Gillum RF, Fortmann SP, Prineas RJ, Kottke TE. International diagnostic criteria for acute myocardial infarction and acute stroke. Am Heart J. 1984;108:150-158.
18. Moorjani S, Dupont A, Labrie F, Lupien PJ, Brun LD, Gagné C, Giguère M, Bélanger A. Increase in plasma high density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma. Metabolism. 1987:36:244-250.
19. 2 precipitation procedures for estimating cholesterol in high-density lipoproteins. Clin Chem. 1978;24:323-338.
20. Gidez LI, Miller GJ, Burstein M, Eder HA. Analysis of plasma high density lipopcotein subclasses by a precipitation procedure: correlation with preparative and analytical ultracentrifugation. In: Lippel K, ed. Report of the High Density Lipoprotein Methodology Workshop. Washington, DC: Dept of Health, Education, and Welfare; 1979:328-335,335X. US Dept of Health, Education, and Welfare publication NIH 79-1661.
21. Chait A, Brunzell JD. Chylomicronemia syndrome. Adv Intern Med. 1992:37:249-273.
22. Bachorik PS, Albers JJ. Precipitation methods for quantification of lipoproteins. Methods Enzymol. 1986;129:78-100.
23. Miller NE, Bolton CH, Hayes TM, Bainton D, Yarnell JWG, Baker IA, Sweetnam PM. Associations of alcohol consumption with plasma high density lipoprotein cholesterol and its major subfractions: the Caerphilly and Speedwell Collaborative Heart Disease Study. J Epidemiol Community Health. 1988;42:220-225.
24. Després JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arterioscler Thromb Vase Biol. 1990;10:497-511.
25. Després JP, Lamarche B. Low intensity aerobic exercise training, plasma lipoproteins and the risk of coronary heart disease. J Intern Med. 1994;236:7-22.
26. Mistry P, Miller NE, Laker M, Hazzard WR, Lewis B. Individual variations in the effects of dietary cholesterol on plasma lipoproteins and cellular cholesterol homeostasis in man. J Clin Invest. 1981;67:493-502.
27. Williams PT, Krauss RM, Wood PD, Albers JJ, Dreon D, Ellsworth N. Associations of diet and alcohol intake with high density lipoprotein subclasses. Metabolism. 1985;34:524-530.
28. Haskell WL, Camargo C, Williams PT, Vranizan KM, Krauss RM, Lindgren FT, Wood PD. The effect of cessation and resumption of moderate alcohol intake on serum high-density-Iipoprotein subfractions. N Eng J Med. 1984;310:805-810.
29. Srivastava LM, Vasisht S, Agarwal DP, Goedde HW. Relation between alcohol intake, lipoproteins and coronary heart disease: the interest continues. Alcohol Alcoholism. 1994;29:11-24.
30. Ridker PM, Vaughan DE, Stampfer MJ, Glynn RJ, Hennekens H. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA. 1994;272:929-933.
31. Criqui MH, Cowan LD, Tyroler HA, Bangdiwala S, Heiss G, Wallace RB, Cohn R. Lipoproteins as mediators for the effects of alcohol onsumption and cigarette smoking on cardiovascular mortality: results from the Lipid Research Clinic Follow-up Study. Am J Epidemiol. 1987;126:629-637.
32. Gaziano JM, Buring JE, Breslow JL, Goldhaber SZ, Rosner B, van Denburgh M, Willett WC, Hennekens CH. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med. 1993;329: 1829-1834.
33. Clevidence BA, Reichman ME, Judd JT, Muesing RA, Schatzkin A, Schaefer EJ, Li Z, Jenner J, Brown CC, Sunkin M, Campbell WS, Taylor PR. Effects of alcohol consumption on lipoproteins of premenopausal women: a controlled diet study. Arterioscler Thromb Vasc Biol. 1995:15:179-184.
34. Spector A, Scanu AM, Kaduce TL, Figard PH, Fless GM, Czervionke RL. Effect of human plasma lipoproteins on prostacyclin production by cultured endothelial cells. J Lipid Res. 1985;26: 288-297.
35. Saku K, Ahmad M, Glas-Greenwalt P, Kashyap ML. Activation of fibrinolysis by apolipoproteins of high density lipoproteins in man. Thromb Res. 1985;39:l-8.
36. Miller NE, Weinstein DB, Carey TE, Koschinsky T, Steinberg D. Interaction between high density and low density lipoproteins during uptake and degradation by cultured human fibroblasts. J Clin Invest. 1987;60:78-89.
37. Robinson D, Ferns GA, Bevan EA, Stocks J, Williams PT, Galton DJ. High density lipoprotein subfractions and coronary risk factors in normal men. Arterioscler Thromb Vasc Biol. 1987;7: 341-346.
38. Phillips AN, Davey Smith G. How independent are 'independent' effects? Relative risk estimation when correlated exposures are measured imprecisely. J Clin Epidemiol. 1991;44:1223-1231.